Searched for
NEPHROPLUS IPO
NephroPlus' Rs 871-cr IPO to open on Dec 10; sets price band at Rs 438-460/shareDialysis services provider Nephrocare Health Services Ltd, known for its brand NephroPlus, on Thursday announced a price band of Rs 438-460...- Aequs IPO Day 2: GMP suggest 37% listing upside, heavy demand. Is it worth applying?Aequs’ IPO saw strong Day 1 demand, getting subscribed 3.42 times, with retail bids soaring past 11 times. The grey market premium suggests...
- NephroPlus announces IPO launch on December 10. Check key detailsNephrocare Health Services’ IPO opens December 10 with a fresh issue and OFS totaling significant funds. Proceeds will support new dialysis...
- NephroPlus set to launch IPO open on Dec 10; eyes Rs 353-cr via fresh issueDialysis services provider Nephrocare Health Services Ltd, known for its brand NephroPlus, is set to launch its initial public offering, co...
- IPO Frenzy Continues: December to see nearly Rs 30,000 crore worth of public issuesDecember promises a surge in India's IPO market, with around 25 public issues worth nearly ₹30,000 crore planned. This follows a record-bre...
- NephroPlus gets Sebi nod to launch IPO, to raise Rs 353 crore from fresh issueDialysis services leader Nephrocare Health Services, operating under NephroPlus, has received Sebi’s approval to launch its IPO, comprising...
- Blockbuster November looms for India’s IPO market with over Rs 76,000 crore worth of issues lined upIndia's IPO market anticipates a blockbuster November, with over ₹76,000 crore in public issues expected across various sectors. This surge...
- IPO-bound NephroPlus scales operations to 500 clinics, across India, Nepal, Philippines, UzbekistanIPO-bound NephroCare Health Services on Wednesday said it has scaled its operations from one clinic in India in 2010 to 500 clinics, across...
- Quadria Capital weighs Encube sale, keeps public float option alive, tooQuadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale ...
- Pharma, healthcare firms eye Rs 13,000-cr IPO wave over 9 monthsIndian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs i...
- NephroPlus files DRHP with Sebi, to raise Rs 353 crore via fresh issueNephrocare Health Services, known as NephroPlus, plans to raise funds through an IPO. The IPO includes fresh shares and an offer for sale. ...
- Dialysis chain NephroPlus eyes Rs 2,000 crore IPONephrocare Health Services, known as NephroPlus, is set to file its DRHP with SEBI by the end of this month, aiming to raise over ₹2,000 cr...
- Ex-Premji invest, International Finance Corporation trio’s fund bags Rs 1,000 croreManipal group chairman Ranjan Pai’s family office Claypond Capital has anchored the fund with capital infusion from over 30 startup founder...
- Quadria Capital to pick up minority stake in drug company AragenQuadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...
- Quadria in talks to buy into dialysis chain NephroPlusQuadria Capital, an Asia-focused private equity fund, is in talks to acquire a significant minority stake in India's largest dialysis chain...
- MediAssist in talks with PEs to raise up to Rs 250 crore ahead of IPO“The company has reached out to mid-size private equity funds to raise up to Rs 250 crore as a pre-IPO round,” said one of the persons with...
Load More- NephroPlus set to launch IPO open on Dec 10; eyes Rs 353-cr via fresh issue
